Therefore, mSEPT9 by itself seemed an unsatisfactory screening biomarker used alone and it is reasonable to think that a combination of mSETP9, KRAS and BRAF may increase CRC detection by ctDNA, but not enough for AA detection. The gene discussed is KRAS; the disease is colorectal carcinoma.